artificial intelligence
C2i Genomics, OncoDNA Enter Strategic Alliance for AI-Based Cancer Detection, Monitoring
The companies and the Gustave Roussy Institute plan to initiate a clinical trial to test the utility of escalating treatments for cancers with high risk of recurrence.
The Israeli government-funded group of biotech, pharma, computational biology, and agriculture interests has developed software for predicting CRISPR guide RNA.
Protai Raises $8M to Build Proteomics, AI-Based Drug Discovery Platform
The Israeli startup expects the funding to support development of drug discovery programs and partnerships with pharma researchers.
The bioinformatics firm hopes its AI and "NASA-style" command center will make it easier to get cancer patients into NGS labs and improve trial matching.
BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally
NEC, an investor in BostonGene, will initially help provide Tumor Portrait to hospitals in Japan using its healthcare and life science network.